Skip to main content
Clinical Trials/JPRN-jRCT1050220051
JPRN-jRCT1050220051
Recruiting
未知

Evaluation of knee function and safety after treatment of articular cartilage damage in knee joints with allogeneic induced pluripotent stem (iPS) cell-derived cartilage.

Matsuda Shuichi0 sites4 target enrollmentJune 16, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Matsuda Shuichi
Enrollment
4
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 16, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Matsuda Shuichi

Eligibility Criteria

Inclusion Criteria

  • Patients who received and completed knee treatment with iPS\-cell\-derived cartilage.

Exclusion Criteria

  • Patients whom the doctors considered inappropriate for the study.
  • 1\) Patients with new\-onset systematic diseases unrelated to the surgery that can not come to the hospital..
  • 2\) Patients who have difficulty coming to the hospital due to relocation.
  • 3\) Patients with new\-onset psychiatric disorders that may influence the conduct and evaluation of this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials